A review of the cardiovascular safety and potential benefits of incretin-based therapies for patients with type 2 diabetes mellitus.
February 2014
Do mandatory follow-up visits after discharging heart failure patients decrease rehospitalizations?
Advertisement
Advertisement
Trending on HCPLive
1
Prevalence and Recognition of Hypercortisolism
2
Screening and Diagnosis of Hypercortisolism in Type 2 Diabetes
3
Skin of Color Savvy—A New Generation of Dermatology Leadership, With Umayr Shaikh, MPH
4
Distinguishing CSU From Chronic Inducible Urticaria Subtypes
5